Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Monte Rosa Therapeutics (GLUE) Asset Utilization Ratio (2024 - 2025)

Monte Rosa Therapeutics (GLUE) has 2 years of Asset Utilization Ratio data on record, last reported at 0.44 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 875.22% year-over-year to 0.44; the TTM value through Sep 2025 reached 0.44, up 875.22%, while the annual FY2024 figure was 0.2, N/A changed from the prior year.
  • Asset Utilization Ratio reached 0.44 in Q3 2025 per GLUE's latest filing, down from 0.47 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.47 in Q2 2025 and bottomed at 0.0 in Q1 2024.